News

Incyte announced that the U.S. Food and Drug Administration (FDA) has approved Opzelura (ruxolitinib) cream 1.5% for the topical treatment of nonsegmental vitiligo in adult and…
Read More...

Amylyx Pharmaceuticals, Inc. announced a two-year sponsored research agreement with Sunnybrook Research Institute (SRI) to expedite the identification of novel drug candidates that…
Read More...

Moderna, Inc. announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a…
Read More...

Everest Medicines announced that our partner Calliditas Therapeutics AB has been granted conditional marketing authorization for Kinpeygo (developed under the name NEFECON) by the…
Read More...

Endo International plc announced that its subsidiary Endo Ventures Limited has entered into agreements with Quoin Pharmaceuticals Inc. for the development, registration, supply,…
Read More...

NeoImmuneTech, Inc. (NIT) announced that the U.S. Food and Drug Administration (FDA) has granted NT-I7 (efineptakin alfa) (rhIL-7-hyFc) Orphan Drug Designation for the treatment of…
Read More...

SK Biopharmaceuticals, Co., Ltd., announced that it has entered into a licensing agreement for Eurofarma, a Brazilian pharmaceutical company with business in over 20 countries, to…
Read More...

Zymergen Inc. announced it has expanded its agreement with Octant to further scale their next-generation platform to develop breakthrough medicines. In May, Octant purchased five…
Read More...

Today, Health Canada authorized the use of the Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age. This is the first COVID-19 vaccine authorized in Canada for use…
Read More...

Codexis, Inc. announced that the Company has entered into an agreement with Pfizer for the supply of a proprietary high-performance enzyme used to manufacture a critical intermediate…
Read More...

Labcorp announced the launch of the first widely accessible test that provides direct evidence of neurodegeneration and neuronal injury. The new Neurofilament Light Chain…
Read More...

Orion Corporation and MSD announced a global development and commercialisation agreement for Orion’s investigational candidate ODM-208 and other drugs targeting cytochrome P450 11A1…
Read More...

Novavax, Inc. announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to…
Read More...

DNAnexus, Inc. and Twist Bioscience Corporation announced a collaboration aimed at accelerating research and reducing the time to design, validate, and commercialize new, high-quality,…
Read More...

AVROBIO, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for AVR-RD-05, its gene therapy for the treatment of mucopolysaccharidosis…
Read More...

Innoviva, Inc. announced that the company has entered into an agreement to sell its 15% economic stake in Theravance Respiratory Company LLC (“TRC”), which receives royalties stemming…
Read More...

Solvias announced that it has acquired Utrecht, Netherlands-based Cergentis. The acquisition bolsters Solvias' platform of biologics and cell and gene therapy (CGT) testing solutions.…
Read More...

Discovery Life Sciences (Discovery), the biospecimen and biomarker specialists, announced its acquisition of AllCells, a leading provider of clinical-grade (GMP-compliant) and Research…
Read More...

On the July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing next-generation chimeric antigen receptor (CAR)-T…
Read More...

Bicycle Therapeutics plc announced that Genentech, a member of the Roche Group, has exercised its second option to initiate a new program, expanding the exclusive strategic…
Read More...